Berkshire Medical Center is a private, non-profit 302-bed community teaching hospital in Pittsfield, Massachusetts affiliated with the University of Massachusetts Medical School.

There are 302 beds in Berkshire Medical Center.

During the past decade, Berkshire Medical Center conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 6 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Berkshire Medical Center" #1 sponsor was "NSABP Foundation Inc" with 7 trials, followed by "Dana-Farber Cancer Institute" with 2 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "Astellas Pharma Global Development, Inc." with 1 trials sponsored and "Astellas Pharma Inc" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Berkshire Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 8 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "American College of Surgeons" with 1 trials as a collaborator, "American Heart Association" with 1 trials as a collaborator and "Berkshire Medical Center" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Berkshire Medical Center" are "Breast Cancer" (9 trials), "Coronary Artery Disease (CAD)" (2 trials), "Angina, Stable" (1 trials), "Celiac Disease" (1 trials) and "Chronic Lymphocytic Leukemia" (1 trials). Many other conditions were trialed in "Berkshire Medical Center" in a lesser frequency.

Most popular intervention types in "Berkshire Medical Center" are "Drug" (16 trials), "Procedure" (3 trials), "Device" (2 trials), "Radiation" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (4 trials), "Placebo" (3 trials), "Cyclophosphamide" (2 trials), "Docetaxel" (2 trials) and "Doxorubicin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Berkshire Medical Center" are 13 trials for "All" genders and 8 trials for "Female" genders.

Currently, there are NaN active trials in "Berkshire Medical Center". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Berkshire Medical Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Berkshire Medical Center, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".